期刊
CHEMICAL COMMUNICATIONS
卷 50, 期 56, 页码 7427-7430出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/c4cc00419a
关键词
-
资金
- National Basic Research Program of China (973 Program) [2012CB932502]
- National Science Foundation of China [U1332210, 21171156, 51390482, 51125012]
Asplatin, a fusion of aspirin and cisplatin, exhibits significant cytotoxicity in tumor cells and almost fully overcomes the drug resistance of cisplatin resistant cells. Asplatin is highly accumulated in cancer cells and is activated upon the reduction by ascorbic acid.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据